Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Expert Opin Emerg Drugs. 2012 Jun;17(2):261–277. doi: 10.1517/14728214.2012.691965

Table 3.

Anti-oxidative and NF-kB inhibitory drugs used in preclinical/clinical studies

Drug/compound Company Status Mode of Action
Antioxidants
   N-acetylcysteine (NAC) *Twinlabs Preclinical Antioxidant
   Green tea extract (Epigallocatechin-Gallate; EGCg) *Nature’s Way Clinical trials Antioxidant
   Melatonin *GNC Clinical trials Antioxidant
   Idebenone Santhera Pharmaceuticals Clinical trials Antioxidant
NF-kB inhibition
   Remicade Merck/Schering-Plough Preclinical Antibody to human TNF-α
   Etanercept Wyeth Preclinical Blocks soluble receptor to TNF-α
   NBD peptide **Enzo Life Science Preclinical Inhibitor of the NF-κB signaling pathway
*

Available over the counter from several sources (e.g., NOW Foods, FoodScience of Vermont)

**

Clinical grade product not available

HHS Vulnerability Disclosure